Dr. Amit Kumar Yadav, Scientist `D’ – NER (Scientific Decision Unit), Department of Biotechnology, at a session on Biofoundry and Biomanufacturing Initiative series,conducted by Department of Biotechnology (DBT), discussed the potential of enzyme...
Taro Pharma, the US division of India's top drug maker Sun Pharmaceuticals Ltd., has reached a agreement with Antibe Therapeutics, a biotech firm from Canada. After the announcement, Sun Pharmaceuticals has agreed to acquire 100% share in Antibe...
Gland Pharma announced that it has secured the establishment inspection report (EIR) from the US drug regulatory authority for its Dundigal site in Hyderabad, marking the conclusion of the inspection. The US Food and Drug Administration (USFDA)...
Odisha government is preparing to establish a pharmaceutical manufacturing hub, which has the potential to significantly impact job creation and economic development in the state. In preparation for the major investment summit Utkarsh Odisha: Make...
Iconovo AB, a company specializing in inhalable medications created with unique inhalers and dry powder formulations, has partnered with Lonza, a healthcare development and manufacturing firm, to develop spray-dried formulations of an intranasal...
Newron Pharmaceuticals S.p.A, a biopharmaceutical firm dedicated to creating innovative treatments for disorders of the central and peripheral nervous systems, along with Myung In Pharm Co. Ltd. (Myung In Pharm), the foremost CNS-focused...
Pharmaceutical firm Lupin Ltd has stated that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its Pithampur Unit-1 manufacturing facility, which produces both APIs and...
India's pharmaceutical industry plans to increase its size to over USD 120-130 billion by 2030, leveraging innovation to establish itself as the global healthcare guardian, according to Samir Mehta, president of the Indian Pharmaceutical Alliance...
India's pharmaceutical industry is expected to show strong earnings growth of 19.4% year-over-year for the October-December quarter (Q3 FY25), fueled by solid domestic formulation (DF) sales, specialized US generic launches, and lower raw material...
The Subject Expert Committee (SEC) operating under the Central Drug Standard Control Organisation (CDSCO) has permitted drug giant Sun Pharma Laboratories to produce and sell Fexuprazan Hydrochloride Tablets 40 mg. Nonetheless, this approval is...
, CDSCO.jpg)
